ADMA Biologics Inc (ADMA) Stock Price Today
Aura AI Summary
Key Stats
- $2.15BMarket Cap
- -Volume
- HealthSector
- $20.3852W High
- $7.6052W Low
- -Typical Hold Time
- $2.22BEnterprise Value
- -Div Yield
- -Trading Activity
Track ADMA Biologics Inc (ADMA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $7.6 and a high of $20.38, highlighting its annual price range. Buy and sell ADMA Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Most Recent News
Smart TV market to hit $923B by 2035, driven by OTT streaming and AI display tech growth
The global smart TV market is projected to grow from $259.51 billion in 2025 to $923.12 billion by 2035, at a CAGR of 13.53%. This growth is fueled by the rise of OTT streaming platforms like Netflix and Disney+, widespread 5G and fiber internet acce...

Nxera Pharma reports Q2 2026 profit on milestone payments and advances in drug development.
Nxera Pharma announced a net profit of JPY 1,591 million (US$10.1 million) for Q2 2026, reversing a prior loss due to multiple milestone payments from partners like Neurocrine, AbbVie, and Lilly. The company progressed regulatory approvals and commer...

Michael Burry bets against Oracle and Nebius stocks amid AI sector concerns.
Michael Burry, known for his bearish bets, has taken new short positions against Oracle and Nebius stocks, citing risks in the AI sector. He previously exited a short on Oracle but re-entered at $144.63, and shorted Nebius at $211.77 due to overprice...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.